康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02162 康诺亚-B

已收盘 12-23 16:08:41

31.850

-0.750

-2.30%

最高33.750	最低31.000	成交量285.80万
今开32.550	昨收32.600	日振幅8.44%
总市值89.10亿	流通市值89.10亿	总股本2.80亿
成交额9,059万	换手率1.02%	流通股本2.80亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康诺亚-B","latestPrice":31.85,"timestamp":1734941321001,"preClose":32.6,"halted":0,"volume":2858000,"delay":0,"floatShares":279735566,"shares":279735566,"eps":-1.4610442,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.75,"latestTime":"12-23 16:08:41","open":32.55,"high":33.75,"low":31,"amount":90592337,"amplitude":0.084356,"askPrice":31.85,"askSize":35500,"bidPrice":31.75,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-3.025600813022027,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"listingDate":1625673600000,"adjPreClose":32.6,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":0.715115,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162/tweets","defaultTab":"tweets","newsList":[{"id":"2492567984","title":"港股异动 | 康诺亚-B(02162)一度跌超10% 股价暂现七连阴 传公司竞品医保续约降价超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2492567984","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492567984?lang=zh_cn&edition=full","pubTime":"2024-12-20 10:36","pubTimestamp":1734662176,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康诺亚-B跌超10%，股价暂现七连阴。消息面上，近日市场流传有关达必妥医保续约降价超预期的消息。值得注意的是，度普利尤单抗自从上市以来价格总体呈现下降趋势。2020年7月在国内刚上市时，度普利尤单抗规格为300mg/支，每支价格高达6666元；2021年3月被纳入医保目录后，该药同规格价格降为每支3160元；去年1月医保续约时，该药同规格价格进一步降至2780元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02162","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2492455888","title":"康诺亚-B盘中异动 早盘快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492455888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492455888?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:59","pubTimestamp":1734659987,"startTime":"0","endTime":"0","summary":"2024年12月20日早盘09时59分，康诺亚-B股票出现波动，股价大幅下挫5.02%。截至发稿，该股报31.250港元/股，成交量75.45万股，换手率0.27%，振幅5.02%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康诺亚-B股票所在的生物技术行业中，整体跌幅为0.08%。康诺亚-B公司简介：康诺亚生物医药科技有限公司是一家生物科技公司,专注于自主发现及开发自体免疫及肿瘤治疗领域的创新生物疗法的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095948a1fc7773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095948a1fc7773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02162","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2492455818","title":"康诺亚-B(02162)下跌5.02%，报31.25元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492455818","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492455818?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:59","pubTimestamp":1734659986,"startTime":"0","endTime":"0","summary":"12月20日，康诺亚-B(02162)盘中下跌5.02%，截至09:59，报31.25元/股，成交2409.87万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法，主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项，其中9项已进入不同阶段临床研发，多项位于中国第一，世界前三，包含一项世界首创ADC新药，两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报，康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/20095946620697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1587","BK1161","BK1583","BK1574","02162"],"gpt_icon":0},{"id":"2492458105","title":"拉升势头被打断，康诺亚-B被竞品降价传闻带出六连跌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2492458105","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492458105?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:47","pubTimestamp":1734659262,"startTime":"0","endTime":"0","summary":"12月17日盘中，康诺亚股价甚至一度下跌至31.7港元，回吐了9月以来的全部涨幅。直至12月19日，康诺亚股价仍未止跌，形成了一波“六连跌”行情。竞品降价带来的商业化挑战作为康诺亚首个获得监管批准上市的药物，司普奇拜单抗能否成功商业化至关重要。如果最终该消息被证实，将对康诺亚的司普奇拜单抗商业化产生较大压力。面对降价幅度高于预期的竞品，康诺亚完成司普奇拜单抗首年销售目标的难度进一步提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095232a1fc72d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095232a1fc72d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1574","BK1161","BK1587","BK1583"],"gpt_icon":0},{"id":"2492941582","title":"创新药概念多数上扬 圣诺医药(02257)涨11.56% 机构指医药创新是医药增长的核心动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2492941582","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492941582?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:55","pubTimestamp":1734486946,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念多数上扬，圣诺医药 涨11.56%，百奥赛图涨9.68%，歌礼制药涨7.98%，绿竹生物涨4.73%，再鼎医药涨4.41%，康诺亚涨1.34%，中国生物制药涨0.95%，信达生物涨0.69%银河证券表示，1）医药创新是医药增长的核心动力。对于医药板块， 在“医保+商保”模式不断推进、政策支持等因素驱动下，行业规模有望进一步扩大。“医保+商保”模式打开健康险空间，创新药发展空间更大。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949850","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02257","BK1587","LU2328871848.SGD","159992","01672","09688","02162","BK1191","01177","BK1583","06978","LU1969619763.USD","BK1161","BK1574","02315","BK1521","09939","BK1515","BK1588","01801","LU2488822045.USD","BK1589","02480","159938"],"gpt_icon":0},{"id":"2492987701","title":"康诺亚-B12月17日获主力加仓355万元 环比增加533.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492987701","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492987701?lang=zh_cn&edition=full","pubTime":"2024-12-17 16:17","pubTimestamp":1734423431,"startTime":"0","endTime":"0","summary":"12月17日, 康诺亚-B股价跌2.46%，报收33.70元，成交金额1.67亿元，换手率1.82%，振幅8.39%，量比3.25。康诺亚-B今日主力资金净流入355万元，连续4日净流入，上一交易日主力净流入56万元，今日环比增加533.93%。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为40.00%，平均涨幅为3.15%。该股近5个交易日下跌20.12%，主力资金累计净流入872万元；近20日主力资金累计净流出2807万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217161815ab7e9479&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217161815ab7e9479&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1583","02162","BK1161"],"gpt_icon":0},{"id":"2492498545","title":"【券商聚焦】国证国际：创新药企和医疗器械公司有望通过出海不断打开市场天花板","url":"https://stock-news.laohu8.com/highlight/detail?id=2492498545","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492498545?lang=zh_cn&edition=full","pubTime":"2024-12-17 14:20","pubTimestamp":1734416402,"startTime":"0","endTime":"0","summary":"对于医药板块， 在“医保+商保”模式不断推进、政策支持等因素驱动下，行业规模有望进一步扩大。由于中美定价差异大，企业可通过license out不断打开市场天花板。“医保+商保”模式打开健康险空间，创新药发展空间更大。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YzgwMTczMTA1NDUyODEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzgwMTczMTA1NDUyODEwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949796","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","159992","BK1222","09996","BK1587","BK1191","159883","01801","BK1521","01177","BK1583","BK1515","BK1181","BK1100","06978","LU2488822045.USD","02162","09997","BK1161","LU2328871848.SGD","BK1574","BK1589","06880"],"gpt_icon":0},{"id":"2492748796","title":"康诺亚-B盘中异动 快速跳水5.21%报32.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492748796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492748796?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:39","pubTimestamp":1734399551,"startTime":"0","endTime":"0","summary":"2024年12月17日早盘09时39分，康诺亚-B股票出现异动，股价快速跳水5.21%。截至发稿，该股报32.750港元/股，成交量17.6046万股，换手率0.06%，振幅5.35%。资金方面，该股资金流入112.142万港元，流出419.88万港元。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康诺亚-B股票所在的生物技术行业中，整体涨幅为0.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093911a1f4701c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093911a1f4701c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1583","BK1574","02162"],"gpt_icon":0},{"id":"2491599576","title":"康诺亚-B12月16日主力资金流入56万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491599576","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491599576?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:17","pubTimestamp":1734337031,"startTime":"0","endTime":"0","summary":"12月16日, 康诺亚-B股价跌8.84%，报收34.55元，成交金额1.43亿元，换手率1.44%，振幅12.14%，量比4.88。康诺亚-B今日主力资金净流入56万元，连续3日净流入，上一交易日主力净流入426万元，今日环比减少86.85%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为3.69%。该股近5个交易日下跌17.52%，主力资金累计净流入666万元；近20日主力资金累计净流出2783万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161757a1f27ae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161757a1f27ae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02162","BK1587"],"gpt_icon":0},{"id":"2491630509","title":"医药股多数承压 来凯医药(02105)跌近11% 机构指板块当前已经处于业绩、政策和资金三重反转的进程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2491630509","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491630509?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:56","pubTimestamp":1734332198,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股多数承压，来凯医药 跌10.94%，康诺亚跌6.07%，金斯瑞生物科技跌5.54%，科伦博泰生物跌4.96%，康方生物跌4.4%，药明生物跌3.15%。国金证券发研指，医药板块当前已经处于业绩、政策和资金三重反转的进程之中，对2025年医药板块上市公司营收利润增速回升、板块行情复苏有充分信心。医保局将指导各地及中选企业做好中选结果落地实施工作，确保全国患者于2025年4月用上本次集采中选产品。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0140636845.USD","LU0348783233.USD","LU0516423091.SGD","LU0359202008.SGD","LU0516423174.USD","LU0307460666.USD","01548","LU0320764599.SGD","LU0043850808.USD","LU0326950275.SGD","LU0348825331.USD","LU0516422952.EUR","LU0348784397.USD","LU1242518857.USD","IE00B0JY6N72.USD","BK1587","LU0181495838.USD","LU0348735423.USD","LU1880383366.USD","HK0000320223.HKD","06990","LU2039709279.SGD","LU0456827905.SGD","HK0000306701.USD","02105","159938","BK1521","LU0456846285.SGD","SG9999002463.SGD","HK0000306685.HKD","09939","09926","BK1583","IE00B5MMRT66.SGD","LU0051755006.USD","LU0979878070.USD","LU0823426480.USD","LU2488822045.USD","LU0417516571.SGD","02162","LU0359201612.USD","LU1242518931.SGD","LU0516422366.SGD","LU0823426308.USD","BK1574","02269","LU0572944931.SGD","LU0588546209.SGD","LU1720050803.USD"],"gpt_icon":1},{"id":"2491631044","title":"康诺亚-B(02162)下跌5.01%，报36.0元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491631044","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491631044?lang=zh_cn&edition=full","pubTime":"2024-12-16 13:18","pubTimestamp":1734326317,"startTime":"0","endTime":"0","summary":"12月16日，康诺亚-B(02162)盘中下跌5.01%，截至13:18，报36.0元/股，成交4493.97万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法，主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项，其中9项已进入不同阶段临床研发，多项位于中国第一，世界前三，包含一项世界首创ADC新药，两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报，康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/16131846412262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02162","BK1583","BK1587","BK1161","BK1574"],"gpt_icon":0},{"id":"2491969639","title":"康诺亚-B盘中异动 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491969639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491969639?lang=zh_cn&edition=full","pubTime":"2024-12-16 13:18","pubTimestamp":1734326309,"startTime":"0","endTime":"0","summary":"2024年12月16日下午盘13时18分，康诺亚-B股票出现异动，股价大幅跳水5.01%。截至发稿，该股报36.000港元/股，成交量122.35万股，换手率0.44%，振幅7.78%。康诺亚-B股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，晶泰控股-P、华康生物医学、嘉和生物-B涨幅较大，振幅较大的相关个股有晶泰控股-P、创胜集团-B、思路迪医药股份，振幅分别为18.53%、18.03%、15.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216131830a1f21b3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216131830a1f21b3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","BK1574","02162","BK1161"],"gpt_icon":0},{"id":"2491390316","title":"康诺亚－Ｂ(02162)股价下跌5.013%，现价港币$36.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2491390316","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491390316?lang=zh_cn&edition=full","pubTime":"2024-12-16 13:18","pubTimestamp":1734326280,"startTime":"0","endTime":"0","summary":"[下跌股]康诺亚－Ｂ(02162) 股价在下午01:18比前收市价下跌5.013%，现股价为港币$36.0。至目前为止，今日最高价为$38.95，而最低价为$36.0。总成交量为122.05万股，总成交金额为港币$4.472千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2412161218/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1587","BK1574","02162","BK1583"],"gpt_icon":0},{"id":"2491345482","title":"康诺亚-B12月13日获主力加仓426万元 环比增加1190.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491345482","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491345482?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:16","pubTimestamp":1734077785,"startTime":"0","endTime":"0","summary":"12月13日, 康诺亚-B股价跌4.65%，报收37.90元，成交金额5112万元，换手率0.48%，振幅5.79%，量比1.77。康诺亚-B今日主力资金净流入426万元，上一交易日主力净流入33万元，今日环比增加1190.91%。该股近5个交易日下跌6.13%，主力资金累计净流入610万元；近20日主力资金累计净流出2753万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161712ab74c0c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161712ab74c0c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02162","BK1574","BK1161","BK1587"],"gpt_icon":0},{"id":"2491085317","title":"康诺亚-B盘中异动 下午盘大幅下跌5.16%报37.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491085317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491085317?lang=zh_cn&edition=full","pubTime":"2024-12-13 15:24","pubTimestamp":1734074683,"startTime":"0","endTime":"0","summary":"2024年12月13日下午盘15时24分，康诺亚-B股票出现异动，股价大幅下挫5.16%。截至发稿，该股报37.700港元/股，成交量100.718万股，换手率0.36%，振幅5.79%。资金方面，该股资金流入1451.78万港元，流出2016.15万港元。康诺亚-B股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，北海康成-B、华康生物医学、圣诺医药-B涨幅较大，振幅较大的相关个股有晶泰控股-P、北海康成-B、圣诺医药-B，振幅分别为35.55%、29.79%、27.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121315244495e95f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121315244495e95f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02162","BK1574","BK1161","BK1587"],"gpt_icon":0},{"id":"2490879827","title":"【券商聚焦】浦银国际对2025年医药板块整体呈乐观态度 看好创新药、医疗器械及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879827","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879827?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:52","pubTimestamp":1733989962,"startTime":"0","endTime":"0","summary":"2)医疗器械：看好创新高值耗材、医疗设备板块。康诺亚核心产品CM310将于2025年迎来首个完整年度商业化，作为首个国产重磅IL4R，该行认为其市场潜力巨大。此外，康诺亚研发实力强劲，NewCo形式有助于加快其出海步伐，2025年潜在出海交易有望进一步提振股票行情。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823426308.USD","LU2125910500.SGD","LU0417516738.SGD","BK1521","09926","LU0572944931.SGD","159883","06160","02269","CXO","LU1720050803.USD","LU0348784397.USD","IE00B5MMRT66.SGD","LU0979878070.USD","BK1610","IE00B543WZ88.USD","LU2328871848.SGD","03759","00013","SG9999014674.SGD","LU0307460666.USD","LU0196878994.USD","LU0819121731.USD","09996","LU0856984785.SGD","LU0516422366.SGD","01789","BK1191","02268","LU2488822045.USD","BK1589","LU0043850808.USD","159938","06990","09939","LU0348735423.USD","SG9999002562.SGD","LU0327786744.USD","02162","LU0181495838.USD","06978","02190","09997","BK1141","LU0359202008.SGD","BK1100","SG9999002463.SGD","LU2045819591.USD","02359","159992"],"gpt_icon":1},{"id":"2490168829","title":"康诺亚-B(02162)下跌5.07%，报39.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490168829","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490168829?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:05","pubTimestamp":1733979918,"startTime":"0","endTime":"0","summary":"12月12日，康诺亚-B(02162)盘中下跌5.07%，截至13:05，报39.3元/股，成交1804.46万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法，主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项，其中9项已进入不同阶段临床研发，多项位于中国第一，世界前三，包含一项世界首创ADC新药，两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报，康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/12130546304719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02162","BK1587","BK1574","BK1583"],"gpt_icon":0},{"id":"2490731829","title":"康诺亚-B盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490731829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490731829?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:05","pubTimestamp":1733979917,"startTime":"0","endTime":"0","summary":"2024年12月12日下午盘13时05分，康诺亚-B股票出现波动，股价大幅下跌5.07%。截至发稿，该股报39.300港元/股，成交量44.7万股，换手率0.16%，振幅6.04%。康诺亚-B股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，思路迪医药股份、晶泰控股-P、北海康成-B涨幅较大，振幅较大的相关个股有思路迪医药股份、晶泰控股-P、帝王国际投资，振幅分别为38.70%、19.44%、18.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212130517ab71771b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212130517ab71771b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","BK1587","02162"],"gpt_icon":0},{"id":"2490829704","title":"康诺亚－Ｂ(02162)股价下跌5.072%，现价港币$39.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2490829704","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490829704?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:05","pubTimestamp":1733979900,"startTime":"0","endTime":"0","summary":"[下跌股]康诺亚－Ｂ(02162) 股价在下午01:05比前收市价下跌5.072%，现股价为港币$39.3。至目前为止，今日最高价为$41.8，而最低价为$39.3。总成交量为44.4万股，总成交金额为港币$1.793千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD241212862/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1587","02162","BK1161","BK1583"],"gpt_icon":0},{"id":"2490748167","title":"康诺亚-B(02162)：CM336 I/II期临床研究最新数据在第66届美国血液学会(ASH)年会上以壁报形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2490748167","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490748167?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:32","pubTimestamp":1733733168,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康诺亚-B 发布公告，其靶向BCMAxCD3的双特异性抗体CM336治疗复发或难治性多发性骨髓瘤的I/II期临床研究最新数据在第66届美国血液学会年会上以壁报形式公布。截至2024年10月30日，该研究共入组68例受试者。安全性评估显示，CM336安全性和耐受性良好。剂量成功递增至160 mg，且尚未达到最大耐受剂量。CM336在治疗复发或难治性多发性骨髓瘤受试者中表现出初步有效性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2463526074.USD","BK4109","BK1583","BK1161","BK1587","02162","BK1574","ASH"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1398},{"period":"1month","weight":-0.185},{"period":"3month","weight":-0.1576},{"period":"6month","weight":-0.0578},{"period":"1year","weight":-0.3137},{"period":"ytd","weight":-0.336}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术，其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.102216},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052845},{"month":3,"riseRate":0,"avgChangeRate":-0.111304},{"month":4,"riseRate":1,"avgChangeRate":0.048679},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.125967},{"month":6,"riseRate":1,"avgChangeRate":0.150041},{"month":7,"riseRate":0.333333,"avgChangeRate":0.066538},{"month":8,"riseRate":0.5,"avgChangeRate":0.01599},{"month":9,"riseRate":0.75,"avgChangeRate":0.035232},{"month":10,"riseRate":0.5,"avgChangeRate":0.051059},{"month":11,"riseRate":0.5,"avgChangeRate":0.048399},{"month":12,"riseRate":0.25,"avgChangeRate":-0.134301}],"exchange":"SEHK","name":"康诺亚-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康诺亚-B,02162,康诺亚-B股票,康诺亚-B股票老虎,康诺亚-B股票老虎国际,康诺亚-B行情,康诺亚-B股票行情,康诺亚-B股价,康诺亚-B股市,康诺亚-B股票价格,康诺亚-B股票交易,康诺亚-B股票购买,康诺亚-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}